NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer…
BOCA RATON, Fla.--(BUSINESS WIRE)--#Dermatology--Integrated Dermatology, the country’s largest independent dermatology provider, is pleased to welcome Kinston Cummings, PA-C, to the…
NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an…
FRAMINGHAM, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Alira Health announced today that it has become the first Platinum CRO…
OIC India Enhances On-Site Capabilities with Structured Clinical and Digital Dentistry Training SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ --…
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…
Published in the Journal of Clinical Oncology, results showed no difference in any outcomes, including overall survival, at two years…
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…
SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Supported by six clinical studies and two safety trials, Kerry's LC40® is the first probiotic…